Literature DB >> 21061130

Results of surgery for sporadic primary hyperparathyroidism in patients with preoperatively negative sestamibi scintigraphy and ultrasound.

Anders O J Bergenfelz1, Göran Wallin, Svante Jansson, Håkan Eriksson, Hans Mårtensson, Peer Christiansen, Eva Reihnér.   

Abstract

PURPOSE: The purpose of this study is to investigate the results of first-time surgery for sporadic primary hyperparathyroidism (pHPT) in patients with preoperatively negative sestamibi scintigraphy and ultrasound.
METHODS: Data were gathered prospectively in a multicenter database for quality control in parathyroid surgery. Between 2004 and 2008, 3,158 patients underwent first-time surgery for sporadic pHPT. A total of 984 patients were subjected to preoperative localization with ultrasound and sestamibi scintigraphy, and in 173 patients, both investigations were negative. Intraoperative findings and early outcome are reported.
RESULTS: One hundred and fifty-five of 173 patients underwent bilateral neck exploration. The median weight of excised parathyroid tissue was 350 mg. In 23 patients (13.3%), the exploration was negative. A total of 112 patients (64.7%) had a histological diagnosis of parathyroid adenoma and 38 patients (22%) had multiglandular disease. Six weeks after operation, 164 patients were available for analysis, and 30 patients (18%) had persistent pHPT. The risk for persistent pHPT increased for patients with few intraoperatively identified (p = 0.001) and excised (p = 0.024) parathyroid glands. Patients operated with intraoperative parathyroid hormone (iOPTH) had lower risk for persistent pHPT 7/79 (9%) compared with 23/85 patients (27%) operated without iOPTH (p = 0.003).
CONCLUSIONS: Negative localization with sestamibi and ultrasound in pHPT infers a highly selected patient population with small parathyroid adenomas, an alarmingly high rate of negative exploration, and an increased risk for persistent disease. The use of iOPTH influences cure rate favorably.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21061130     DOI: 10.1007/s00423-010-0724-0

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  16 in total

1.  Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it "value-add" to decision-making?

Authors:  Peter Stalberg; Stan Sidhu; Mark Sywak; Bruce Robinson; Margaret Wilkinson; Leigh Delbridge
Journal:  J Am Coll Surg       Date:  2006-05-30       Impact factor: 6.113

2.  Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery.

Authors:  Anders O J Bergenfelz; Per Hellman; Barney Harrison; Antonio Sitges-Serra; Henning Dralle
Journal:  Langenbecks Arch Surg       Date:  2009-07-03       Impact factor: 3.445

3.  Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial.

Authors:  Anders Bergenfelz; Pia Lindblom; Sten Tibblin; Johan Westerdahl
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

4.  Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism.

Authors:  R Mihai; F F Palazzo; F V Gleeson; G P Sadler
Journal:  Br J Surg       Date:  2007-01       Impact factor: 6.939

Review 5.  Intraoperative adjuncts in surgery for primary hyperparathyroidism.

Authors:  Barney J Harrison; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

6.  Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients.

Authors:  Anders O J Bergenfelz; Svante K G Jansson; Göran K Wallin; Hans G Mårtensson; Lars Rasmussen; Håkan L O Eriksson; Eva I M Reihnér
Journal:  Langenbecks Arch Surg       Date:  2009-07-18       Impact factor: 3.445

7.  Correlations between biochemical testing, pathology findings and preoperative sestamibi scans: a retrospective study of the minimally invasive radioguided parathyroidectomy (MIRP) approach.

Authors:  Stanislaw Peter Stawicki; Maher El Chaar; Daniel R Baillie; Nikhil P Jaik; Fernando P Estrada
Journal:  Nucl Med Rev Cent East Eur       Date:  2007

8.  Surgeon performed ultrasound facilitates minimally invasive parathyroidectomy by the focused lateral mini-incision approach.

Authors:  Patsy S H Soon; Leigh W Delbridge; Mark S Sywak; Beverley M Barraclough; Pam Edhouse; Stan B Sidhu
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

9.  Surgery for patients with primary hyperparathyroidism and negative sestamibi scintigraphy--a feasibility study.

Authors:  Mark Thier; Erik Nordenström; Anders Bergenfelz; Johan Westerdahl
Journal:  Langenbecks Arch Surg       Date:  2009-06-23       Impact factor: 3.445

Review 10.  Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations.

Authors:  Radu Mihai; Marcin Barczynski; Maurizio Iacobone; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2009-06-25       Impact factor: 3.445

View more
  26 in total

1.  Feasibility of unilateral parathyroidectomy in patients with primary hyperparathyroidism and negative or discordant localization studies.

Authors:  Pietro Giorgio Calò; Fabio Medas; Giulia Loi; Enrico Erdas; Giuseppe Pisano; Angelo Nicolosi
Journal:  Updates Surg       Date:  2016-01-29

Review 2.  [Localization of parathyroid adenomas with C11-methionine PET-CT].

Authors:  T Weber; M Luster
Journal:  Chirurg       Date:  2014-07       Impact factor: 0.955

3.  18F-Fluorocholine PET/CT as a second line nuclear imaging technique before surgery for primary hyperparathyroidism.

Authors:  Alessio Imperiale; David Taïeb; Elif Hindié
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04       Impact factor: 9.236

4.  Primary hyperparathyroidism: an analysis of failure of parathyroidectomy.

Authors:  A Bagul; H P Patel; D Chadwick; B J Harrison; S P Balasubramanian
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

5.  The value of intraoperative PTH measurements in patients with mild primary hyperparathyroidism.

Authors:  Thomas D Hathaway; Gareth Jones; Michael Stechman; David Scott-Coombes
Journal:  Langenbecks Arch Surg       Date:  2013-04-26       Impact factor: 3.445

6.  Diagnostic value of four-dimensional computed tomography and four-dimensional magnetic resonance imaging in primary hyperparathyroidism when first-line imaging was inadequate.

Authors:  N Acar; M Haciyanli; M Coskun; N K Erdogan; S C Celik; S G Haciyanli; E O Gur
Journal:  Ann R Coll Surg Engl       Date:  2020-01-10       Impact factor: 1.891

7.  18F-Fluorocholine PET/CT and Parathyroid 4D Computed Tomography for Primary Hyperparathyroidism: The Challenge of Reoperative Patients.

Authors:  Coralie Amadou; Géraldine Bera; Malek Ezziane; Linda Chami; Thierry Delbot; Agnès Rouxel; Monique Leban; Genevieve Herve; Fabrice Menegaux; Laurence Leenhardt; Aurélie Kas; Christophe Trésallet; Cécile Ghander; Charlotte Lussey-Lepoutre
Journal:  World J Surg       Date:  2019-05       Impact factor: 3.352

8.  Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?

Authors:  Theresia Weber; Martin Gottstein; Sabrina Schwenzer; Ambros Beer; Markus Luster
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

9.  Diagnostic value and clinical impact of complementary CT scan prior to surgery for non-localized primary hyperparathyroidism.

Authors:  B Seeliger; P F Alesina; J-A Koch; J Hinrichs; B Meier; M K Walz
Journal:  Langenbecks Arch Surg       Date:  2015-02-22       Impact factor: 3.445

10.  Management of thyroid nodules incidentally discovered on MIBI scanning for primary hyperparathyroidism.

Authors:  Tristan Greilsamer; Claire Blanchard; Niki Christou; Delphine Drui; Catherine Ansquer; Maelle Le Bras; Bertrand Cariou; Cécile Caillard; Emmanuelle Mourrain-Langlois; Anne Sophie Delemazure; Muriel Mathonnet; Françoise Kraeber-Bodéré; Eric Mirallié
Journal:  Langenbecks Arch Surg       Date:  2015-02-20       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.